{
    "Trade/Device Name(s)": [
        "Xpert\u00ae Flu/RSV XC Assay",
        "Xpert Flu/RSV XC Assay",
        "Xpert\u00ae Nasopharyngeal Sample Collection Kit"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K142045",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110968",
        "K132129",
        "K123191",
        "K042970"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI"
    ],
    "Summary Letter Date": "October 21, 2014",
    "Summary Letter Received Date": "October 22, 2014",
    "Submission Date": "November 17, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus",
        "Respiratory syncytial virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [
        "Xpert viral transport medium",
        "Copan Universal Transport Medium (UTM-RT)",
        "Plastic medical-grade polypropylene tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Instrument Systems",
        "GeneXpert Dx Systems",
        "GeneXpert Infinity Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time RT-PCR",
        "Multiplex PCR",
        "Reverse transcriptase PCR"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Flu/RSV XC multiplex RT-PCR assay for qualitative detection and differentiation of influenza A, influenza B, and RSV viral RNA from respiratory specimens.",
    "Indications for Use Summary": "Automated, multiplex real-time RT-PCR assay for in vitro qualitative detection and differentiation of influenza A, influenza B, and RSV viral RNA from nasopharyngeal swab and nasal aspirate/wash specimens in patients with respiratory infection symptoms, as an aid in diagnosis alongside clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}